Article
Las Vegas -- Recent innovations in topical therapies are providing valuable alternatives for the management of some challenging dermatologic conditions, said Mark Lebwohl, M.D., at the Fall Clinical Dermatology Conference.
The Weekly Roundup: September 30-October 4
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Q+A: Roflumilast cream 0.15% for AD with Eric Simpson, MD, MCR, FAAD
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
9 Months of Treatment With Tralokinumab Results in Improved QoL, Itch, and Sleep
Thyroid Disorders and Their Link to Alopecia Areata